INTERVIEWS | |
Semochkin SV |
|
LYMPHOID TUMORS | |
Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma Bessmeltsev SS, Karyagina EV, Ilyushkina EYu, Stolypina ZhL, Miftakhova RR, Kostroma II, Shelkovskaya TL |
|
Smol’yaninova AK, Moskalets ER, Yatsyk GA, Kostina IE, Bogolyubskaya AS, Gabeeva NG, Gemdzhian EG, Tatarnikova SA, Badmadzhapova DS, Zvonkov EE |
|
Characteristics of Hematopoiesis in Follicular Lymphoma Patients Frenkel MA, Mozhenkova AV, Kupryshina NA, Falaleeva NA, Tupitsyn NN |
|
MYELOID TUMORS | |
Overt and Masked Polycythemia Vera Within the Scope of Ph-Negative Myeloproliferative Diseases Tratsevskaya ZhV, Kovrigina AM, Chebotarev DI, Melikyan AL, Abdullaev AO, Sudarikov AB |
|
Zaitsev DV, Girshova LL, Ivanov VV, Budaeva IG, Motorin DV, Badaev RSh, Bogdanov KV, Mirolyubova YuV, Nikulina TS, Zagorodnikova KA, Zhukova NA, Efremova SV, Chitanava TV, Alekseeva YuA, Zaritskey AY |
|
BONE MARROW TRANSPLANTATION | |
Mamaev NN, Shakirova AI, Barkhatov IM, Gudozhnikova YaV, Gindina TL, Paina OV, Zubarovskaya LS, Afanas’ev BV |
|
Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation Drokov MYu, Dmitrova AA, Kuzmina LA, Vasil’eva VA, Mikhaltsova ED, Koroleva OM, Usikova EV, Parovichnikova EN, Savchenko VG |
|
REVIEWS | |
Danilenko AA, Shakhtarina SV, Falaleeva NA |
|
ANTINEOPLASTIC THERAPY COMPLICATIONS | |
Makeeva LM, Emelina EI, Bykova AV, Gendlin GE, Gusarova GA, Nikitin IG, Chelysheva EYu, Vinogradova OYu, Lazarev IE, Arshanskaya EG, Turkina AG |
|
NEWS | |
Resolution of Advisory Panel for the Therapy of Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
|